Suppr超能文献

疾病的交感语境——青光眼管理的新时代。

Sympathetic context of the disease - a new era in glaucoma management.

机构信息

Ophthalmology Department, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

Ophthalmology Department, Clinical Hospital of Ophthalmologic Emergencies, Bucharest, Romania.

出版信息

Rom J Ophthalmol. 2021 Jan-Mar;65(1):15-19. doi: 10.22336/rjo.2021.4.

Abstract

Primary open angle glaucoma (POAG) is a multifactorial optic neuropathy, which progresses in a chronic manner. Several etiological factors are involved, including genetic factors, race, age, IOP or vascular, systemic factors. IOP has an established role in the initiation and evolution of glaucoma, but its interactions with additional risk factors are complex. We propose the notion of the Glaucoma Etiological Area (GEA), as a representation of all the elements acting in collaboration in the physiopathology of each glaucoma case. When combined in different proportions, these elements may trigger the typical glaucomatous optic neuropathy (GON). We know that the statistical values of IOP are valid for normal eyes, but the glaucoma eye is not a normal eye. The notion of GEA can open a new perspective to interpret IOP values and to assess the true value of IOP control as a treatment for glaucoma. Applying the GEA theory allows us to tune the role of IOP. Additional factors, such as ocular properties (RGCL status, CCT, IOP fluctuation curve), ocular comorbidities (PEX, PDS), systemic comorbidities (arterial hypertension, vasospastic diseases such as migraines or Reynaud's syndrome) or patient's attitude towards glaucoma management (treatment compliance, access to follow-up and treatment) may greatly influence the evolution of GON and should be viewed holistically when developing a management plan for each patient. Applying the notion of GEA in clinical practice allows a more realistic approach of the pathophysiology of the disease and for a glaucoma treatment that is tailored to each patient. AG = advanced glaucoma, BP = blood pressure, CCT = central corneal thickness, CIGTS = Collaborative Initial Glaucoma Treatment Study, CNTGS = Collaborative Normal-Tension Glaucoma Study, EMGT = Early Manifest Glaucoma Trial, GEA = glaucoma etiological area, GON = glaucomatous optic neuropathy, IOP = intraocular pressure, NTG = Normal Tension Glaucoma, OHTS = Ocular Hypertension Study, PDS = Pigmentary dispersion syndrome, PEX = Pseudoexfoliation syndrome, POAG - primary open-angle glaucoma, RGCL = retinal ganglion cell layer, VFL = visual field loss.

摘要

原发性开角型青光眼(POAG)是一种多因素的视神经病变,呈慢性进展。涉及多种病因因素,包括遗传因素、种族、年龄、眼压或血管、全身因素。眼压在青光眼的发生和进展中起重要作用,但它与其他危险因素的相互作用非常复杂。我们提出青光眼病因区域(GEA)的概念,作为代表每个青光眼病例的病理生理中协同作用的所有因素的表示。当这些因素以不同的比例组合时,可能会引发典型的青光眼视神经病变(GON)。我们知道眼压的统计值对正常眼有效,但青光眼眼不是正常眼。GEA 的概念可以为我们提供一个新的视角来解释眼压值,并评估眼压控制作为青光眼治疗的真正价值。应用 GEA 理论可以调整眼压的作用。其他因素,如眼部特征(RGCL 状态、CCT、眼压波动曲线)、眼部合并症(PEX、PDS)、全身合并症(高血压、偏头痛或雷诺氏综合征等血管痉挛性疾病)或患者对青光眼管理的态度(治疗依从性、获得随访和治疗),可能会极大地影响 GON 的进展,在为每位患者制定管理计划时应全面考虑这些因素。在临床实践中应用 GEA 的概念可以更现实地了解疾病的病理生理学,并为每位患者量身定制青光眼治疗方案。AG=晚期青光眼,BP=血压,CCT=中央角膜厚度,CIGTS=合作性初始青光眼治疗研究,CNTGS=合作性正常眼压青光眼研究,EMGT=早期显性青光眼试验,GEA=青光眼病因区域,GON=青光眼视神经病变,IOP=眼压,NTG=正常眼压青光眼,OHTS=眼压升高研究,PDS=色素播散综合征,PEX=假性剥脱综合征,POAG-原发性开角型青光眼,RGCL=视网膜神经节细胞层,VFL=视野丧失。

相似文献

2
Is "normal tension glaucoma" glaucoma?“正常眼压性青光眼”是青光眼吗?
Med Hypotheses. 2019 Dec;133:109405. doi: 10.1016/j.mehy.2019.109405. Epub 2019 Sep 24.
5
What is glaucomatous optic neuropathy?什么是青光眼性视神经病变?
Jpn J Ophthalmol. 2020 May;64(3):243-249. doi: 10.1007/s10384-020-00736-1. Epub 2020 May 12.
7
[Aiming for zero blindness].追求零失明
Nippon Ganka Gakkai Zasshi. 2015 Mar;119(3):168-93; discussion 194.

本文引用的文献

3
Neuroprotective agents in the management of glaucoma.神经保护剂在青光眼治疗中的应用。
Eye (Lond). 2018 May;32(5):938-945. doi: 10.1038/s41433-018-0050-2. Epub 2018 Feb 23.
5
Glaucoma history and risk factors.青光眼病史及危险因素。
J Optom. 2017 Apr-Jun;10(2):71-78. doi: 10.1016/j.optom.2016.02.003. Epub 2016 Mar 23.
6
Relationship between intraocular pressure and glaucoma onset and progression.眼压与青光眼发病和进展的关系。
Curr Opin Pharmacol. 2013 Feb;13(1):32-5. doi: 10.1016/j.coph.2012.09.014. Epub 2012 Oct 31.
7
Ocular perfusion pressure and ocular blood flow in glaucoma.青光眼的眼灌注压和眼血流。
Curr Opin Pharmacol. 2013 Feb;13(1):36-42. doi: 10.1016/j.coph.2012.09.003. Epub 2012 Sep 23.
9
Risk factors for visual field progression in treated glaucoma.青光眼治疗后视野进展的危险因素
Arch Ophthalmol. 2011 May;129(5):562-8. doi: 10.1001/archophthalmol.2011.72.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验